The organizers of a genome editing summit are still grappling with the fallout of the scandal and the intense ethical debate it ignited.March 3, 2023Check out STAT+Sponsored By ISAAC LAWRENCE/AFP via Getty Images STAT+ | Ahead of genome summit in London, questions linger about CRISPR baby scandal The organizers of the genome summit are still grappling with the fallout of the 2018 CRISPR baby scandal and the ethical debate it ignited. By Megan Molteni STAT+ | The other way the government is privatizing Medicare This year, Medicare launched a new type of accountable care organization with a structure that looks a lot like Medicare Advantage. By John Wilkerson Opinion: Adoption is not a simple or easy alternative to abortion The Supreme Court alluded to adoption as an alternative to abortion. What might sound fine in a footnote doesn't translate to the real world. By Laura Goetz Presbyterian Healthcare Services STAT+ | Presbyterian and UnityPoint propose latest cross-market hospital merger Because regulators have sunk deals they say would command too much market share in a given region, hospitals are seeking partners in far-flung states. By Tara Bannow Opinion: How physician wellness programs keep doctors captive Wellness programs put the onus of resolving burnout on individual physicians. That's wrong, especially since these programs don't work. By Mark G. Shrime More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments